🌎 Netflix Upgraded, Novo Nordisk A/S Upgraded, Merck &…

Ratings changes for Micron Technology, Nebius Group, Apple, SoundHound AI, Netflix, Verisk Analytics, Wingstop and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

Unsubscribe.

VIEW MY PORTFOLIO

SEPTEMBER 17TH, 2025

The Altcoin That Could be Poised to Benefit Most from Trump’s Return (ad)

With Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And according to Weiss Ratings analyst Juan Villaverde, a major shift is coming.

Juan has nailed every major Bitcoin move since 2012—but right now, he says the biggest upside isn’t in BTC or ETH. It’s in a lesser-known altcoin he believes could become the “third pillar of crypto”… and potentially define America’s first true crypto presidency.

SEE WHY WASHINGTON INSIDERS ARE QUIETLY BUYING THIS COIN BEFORE IT GOES PUBLIC.

Today’s Top Stories

Hong Kong leader unveils plans to boost economy and nurture emerging industries beyond finance

BY THE ASSOCIATED PRESS | SEPTEMBER 17, 2025 12:52 AM

MXRX Planning To List On The Nasdaq (Ad)

BY MED-X INC

Wall Street quiet as market focus turns to an expected interest rate cut by the Federal Reserve

BY THE ASSOCIATED PRESS | SEPTEMBER 16, 2025 10:26 PM

The Federal Reserve wrestles with how many interest rate cuts to make and how fast

BY THE ASSOCIATED PRESS | SEPTEMBER 16, 2025 05:11 PM

Arizona-made nanochips the new millionaire maker? (Ad)

BY BANYAN HILL PUBLISHING

If a Recession Is Coming, You’ll Want to Own These 2 Stocks

BY JORDAN CHUSSLER | SEPTEMBER 16, 2025 10:29 AM

Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust

BY THE ASSOCIATED PRESS | SEPTEMBER 16, 2025 10:27 AM

Quick Links

Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Stock Screener Calculators Premium Reports Best Stocks to Buy in September

New Banking Law #1582 Could Unlock $21 Trillion for Americans (ad)

Do you have money in any of these banks?

Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp.

If you do…

CLICK HERE NOW BECAUSE THEY’RE PREPARING FOR WHAT COULD BE THE BIGGEST CHANGE TO OUR FINANCIAL SYSTE

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Apple Inc. (AAPL)

$239.63 +1.48 (+0.62%) As of 9/17/2025 9:48 AM ET

Apple (NASDAQ:AAPL) had its price target raised by Tigress Financial ( ) (analyst Ivan Feinseth) from $300.00 to $305.00. They now have a “strong-buy” rating on the stock. This represents a 28.1% upside from the current price of $238.15.
Apple’s Crippled China Sales 9/17 – 247WALLST
Tigress Financial Issues Positive Forecast for Apple (NASDAQ:AAPL) Stock Price 9/17 – MARKETBEAT
Apple’s Strong Growth Potential Driven by AI Innovation and Ecosystem Expansion 9/17 – TIPRANKS
Unlock Life-Changing Returns with These 3 Emerging Tech Innovators 9/17 – 247WALLST
Apple Stock’s Not-So-Magnificent Year: Can AI, iPhone 17 Close the Gap with Big Tech Peers?9/17 – INVESTOPEDIA

Amazon.com, Inc. (AMZN)

$231.53 -2.52 (-1.08%) As of 9/17/2025 9:48 AM ET

Stock Chart Expert Explains Why Amazon.com (AMZN) Will Jump 9/17 – INSIDERMONKEY
Amazon investing over $1 billion to raise employee pay-and-lower health care costs 9/17 – REUTERS
Amazon Aims to Grow Ad Sales Further by Automating Creation 9/17 – WSJ
Billionaire Bill Ackman Just Bought Shares of This Company That’s Already Scored a $123 Billion AI Win9/17 – FOOL
Trinity Financial Advisors LLC Grows Position in Amazon.com, Inc. $AMZN 9/17 – MARKETBEAT

Alphabet Inc. (GOOGL)

$251.21 +0.05 (+0.02%) As of 9/17/2025 9:48 AM ET

CAO Amie Thuener O’toole sold 2,778 shares of the firm’s stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $245.00, for a total transaction of $680,610.00. Following the completion of the sale, the chief accounting officer directly owned 17,293 shares in the company, valued at $4,236,785. This trade represents a 13.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Director John L. Hennessy sold 600 shares of the firm’s stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $249.44, for a total transaction of $149,664.00. Following the completion of the sale, the director owned 5,716 shares of the company’s stock, valued at approximately $1,425,799.04. This trade represents a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Waymo is launching robotaxis with Uber rival Lyft 9/17 – BUSINESSINSIDER
Waymo bringing robotaxis to Nashville through first commercial deal with Lyft 9/17 – CNBC
Shell’s Unit to Oversee Carbon-Free Energy for Google UK 9/17 – ZACKS
After Hitting $3 Trillion, Can Alphabet Dethrone Nvidia as Most Valuable Stock? 9/17 – 247WALLST
Alphabet (NASDAQ:GOOGL) Director John Hennessy Sells 600 Shares 9/17 – INSIDERTRADES

Meta Platforms, Inc. (META)

$773.65 -5.35 (-0.69%) As of 9/17/2025 9:48 AM ET

Meta Platforms (NASDAQ: META) Price Prediction and Forecast 2025-2030 for September 17 9/17 – 247WALLST
AMZN, MSFT and META Forecast – Major US Stocks Mixed in Quiet Premarket Trading 9/17 – FXEMPIRE
Prediction: This Underrated AI Stock Could Be the Next $3 Trillion Giant 9/17 – FOOL
Meta Wants AI-Powered Smart Glasses to Drive New Growth 9/17 – INVESTOPEDIA
Accelerating India’s AI Adoption: SAM, Hogan Lovells, Cooley act on $100 million Reliance–Meta JV9/17 – BARANDBENCH

Microsoft Corporation (MSFT)

$507.52 -1.52 (-0.30%) As of 9/17/2025 9:48 AM ET

AMZN, MSFT and META Forecast – Major US Stocks Mixed in Quiet Premarket Trading 9/17 – FXEMPIRE
Australia’s Canva Wants to Take on Adobe, Google, and Microsoft. But Can It? 9/17 – TIPRANKS
Big Tech companies pledge $42 billion in U.K. investments as U.S. President Donald Trump begins state visit9/17 – FORTUNE
Microsoft Corporation $MSFT Shares Sold by Neville Rodie & Shaw Inc. 9/17 – MARKETBEAT
Jacobs & Co. CA Lowers Holdings in Microsoft Corporation $MSFT 9/17 – MARKETBEAT

MANAGE YOUR WATCHLIST

Analysts’ Upgrades

AbbVie (NYSE:ABBV) was upgraded by analysts at Berenberg Bank from a “hold” rating to a “buy” rating. They now have a $270.00 price target on the stock, up previously from $170.00. This represents a 23.1% upside from the current price of $219.35.

Kroger (NYSE:KR) was upgraded by analysts at Roth Capital from a “neutral” rating to a “buy” rating. They now have a $75.00 price target on the stock. This represents a 11.5% upside from the current price of $67.29.

Kroger (NYSE:KR) was upgraded by analysts at Roth Mkm from a “neutral” rating to a “buy” rating. They now have a $75.00 price target on the stock, up previously from $66.00. This represents a 11.5% upside from the current price of $67.29.

Kilroy Realty (NYSE:KRC) was upgraded by analysts at Scotiabank from a “sector underperform” rating to a “sector perform” rating. They now have a $47.00 price target on the stock, up previously from $40.00. This represents a 6.0% upside from the current price of $44.35.

MasTec (NYSE:MTZ) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating. They now have a $227.00 price target on the stock. This represents a 16.0% upside from the current price of $195.61.

Netflix (NASDAQ:NFLX) was upgraded by analysts at Loop Capital from a “hold” rating to a “buy” rating. They now have a $1,350.00 price target on the stock, up previously from $1,150.00. This represents a 11.3% upside from the current price of $1,213.47.

Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at Berenberg Bank from a “hold” rating to a “buy” rating.The current price is $58.56.

Ormat Technologies (NYSE:ORA) was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $102.00 price target on the stock, up previously from $90.00. This represents a 9.2% upside from the current price of $93.44.

Ryan Specialty (NYSE:RYAN) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $60.00 price target on the stock. This represents a 11.1% upside from the current price of $53.98.

Vistra (NYSE:VST) was upgraded by analysts at Daiwa Capital Markets from a “neutral” rating to a “buy” rating. They now have a $250.00 price target on the stock. This represents a 18.3% upside from the current price of $211.32.

VTEX (NYSE:VTEX) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $6.50 price target on the stock. This represents a 43.6% upside from the current price of $4.53.

Workday (NASDAQ:WDAY) was upgraded by analysts at Piper Sandler from an “underweight” rating to a “neutral” rating. They now have a $235.00 price target on the stock, up previously from $220.00. This represents a 1.0% downside from the current price of $237.43.

Workday (NASDAQ:WDAY) was upgraded by analysts at Guggenheim from a “neutral” rating to a “buy” rating. They now have a $285.00 price target on the stock. This represents a 20.0% upside from the current price of $237.43.

Zillow Group (NASDAQ:Z) was upgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating. They now have a $105.00 price target on the stock. This represents a 14.4% upside from the current price of $91.82.

Zillow Group (NASDAQ:ZG) was upgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating. They now have a $105.00 price target on the stock, up previously from $75.00. This represents a 19.1% upside from the current price of $88.17.

VIEW MORE UPGRADES

These 5 Stocks Are Already Moving Under Trump’s Presidency (ad)

Trump’s return is already reshaping the markets—and new winners are emerging fast.

A free report reveals 5 stocks gaining early momentum under the new administration, plus sector trends and portfolio strategies for Trump’s second term.

DOWNLOAD THE REPORT: 5 STOCKS TO BUY UNDER TRUMP’S PRESIDENCY

Analysts’ Downgrades

American Homes 4 Rent (NYSE:AMH) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $37.00 price target on the stock. This represents a 10.9% upside from the current price of $33.36.

Camden Property Trust (NYSE:CPT) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “sell” rating. They now have a $106.00 price target on the stock. This represents a 1.3% downside from the current price of $107.38.

The Hain Celestial Group (NASDAQ:HAIN) was downgraded by analysts at Stephens from an “overweight” rating to an “equal weight” rating. They now have a $2.00 price target on the stock. This represents a 37.5% upside from the current price of $1.46.

Merck & Co., Inc. (NYSE:MRK) was downgraded by analysts at Berenberg Bank from a “buy” rating to a “hold” rating. They now have a $90.00 price target on the stock, down previously from $100.00. This represents a 10.2% upside from the current price of $81.71.

Nintendo (OTCMKTS:NTDOY) was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” rating.The current price is $23.55.

Progressive (NYSE:PGR) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $250.00 price target on the stock. This represents a 3.7% upside from the current price of $241.07.

TPG RE Finance Trust (NYSE:TRTX) was downgraded by analysts at Citizens Jmp from an “outperform” rating to a “market perform” rating.The current price is $9.17.

Tenaris (NYSE:TS) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $41.00 price target on the stock. This represents a 15.6% upside from the current price of $35.48.

Vericel (NASDAQ:VCEL) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $32.54.

VIEW MORE DOWNGRADES

These 5 Stocks Are Thriving Under Trump’s Presidency (ad)

Trump is back in the White House—and new market winners are already emerging.

A free report reveals 5 stocks poised to benefit from early policy shifts, sector momentum, and the evolving 2025 economy.

DOWNLOAD YOUR FREE REPORT: 5 BEST STOCKS FOR TRUMP’S AMERICA

Analysts’ New Coverage

Avient (NYSE:AVNT) is now covered by analysts at KeyCorp. They set an “overweight” rating and a $48.00 price target on the stock. This represents a 33.0% upside from the current price of $36.10.

Biohaven (NYSE:BHVN) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $28.00 price target on the stock. This represents a 98.8% upside from the current price of $14.08.

C4 Therapeutics (NASDAQ:CCCC) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $8.00 price target on the stock. This represents a 135.3% upside from the current price of $3.40.

Exelixis (NASDAQ:EXEL) is now covered by analysts at Barclays PLC. They set an “equal weight” rating and a $40.00 price target on the stock. This represents a 0.0% upside from the current price of $39.99.

Exelixis (NASDAQ:EXEL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $47.00 price target on the stock. This represents a 17.5% upside from the current price of $39.99.

Five Below (NASDAQ:FIVE) is now covered by analysts at Sanford C. Bernstein. They set a “market perform” rating and a $160.00 price target on the stock. This represents a 6.0% upside from the current price of $151.00.

Hagerty (NYSE:HGTY) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an “outperform” rating and a $15.00 price target on the stock. This represents a 20.0% upside from the current price of $12.50.

Janux Therapeutics (NASDAQ:JANX) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $47.00 price target on the stock. This represents a 93.2% upside from the current price of $24.33.

Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $60.00 price target on the stock. This represents a 20.2% upside from the current price of $49.92.

Merus (NASDAQ:MRUS) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $112.00 price target on the stock. This represents a 64.8% upside from the current price of $67.98.

Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $72.00 price target on the stock. This represents a 19.8% upside from the current price of $60.10.

Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Roth Capital. They set a “buy” rating and a $62.00 price target on the stock. This represents a 48.4% upside from the current price of $41.78.

SAB Biotherapeutics (NASDAQ:SABS) is now covered by analysts at Leerink Partners. They set an “outperform” rating and a $7.00 price target on the stock. This represents a 218.2% upside from the current price of $2.20.

StandardAero (NYSE:SARO) is now covered by analysts at Susquehanna. They set a “positive” rating and a $34.00 price target on the stock. This represents a 23.3% upside from the current price of $27.57.

Summit Therapeutics (NASDAQ:SMMT) is now covered by analysts at Barclays PLC. They set an “underweight” rating and a $13.00 price target on the stock. This represents a 29.0% downside from the current price of $18.31.

Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $45.00 price target on the stock. This represents a 36.6% upside from the current price of $32.94.

Terns Pharmaceuticals (NASDAQ:TERN) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $15.00 price target on the stock. This represents a 97.4% upside from the current price of $7.60.

VIEW MORE NEW COVERAGE

Calendars from MarketBeat

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

FDA Calendar

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

GET 30 DAYS OF MARKETBEAT ALL ACCESS FREE

Best-in-Class Portfolio Monitoring

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools

Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

Get 50% off Grammarly Pro’s major upgrade

📖 What does “woolgathering” mean?

RJ Hamster

🌎 Netflix Upgraded, Novo Nordisk A/S Upgraded, Merck & Co., Inc. Downgraded and more…

🌎 Netflix Upgraded, Novo Nordisk A/S Upgraded, Merck &…

SEPTEMBER 17TH, 2025

The Altcoin That Could be Poised to Benefit Most from Trump’s Return (ad)

Today’s Top Stories

Hong Kong leader unveils plans to boost economy and nurture emerging industries beyond finance

MXRX Planning To List On The Nasdaq (Ad)

Wall Street quiet as market focus turns to an expected interest rate cut by the Federal Reserve

The Federal Reserve wrestles with how many interest rate cuts to make and how fast

Arizona-made nanochips the new millionaire maker? (Ad)

If a Recession Is Coming, You’ll Want to Own These 2 Stocks

Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust

Quick Links

New Banking Law #1582 Could Unlock $21 Trillion for Americans (ad)

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Analysts’ Upgrades

These 5 Stocks Are Already Moving Under Trump’s Presidency (ad)

Analysts’ Downgrades

These 5 Stocks Are Thriving Under Trump’s Presidency (ad)

Analysts’ New Coverage

Calendars from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Like this:

🌎 Netflix Upgraded, Novo Nordisk A/S Upgraded, Merck & Co., Inc. Downgraded and more…

SEPTEMBER 17TH, 2025

The Altcoin That Could be Poised to Benefit Most from Trump’s Return (ad)

Today’s Top Stories

Quick Links

New Banking Law #1582 Could Unlock $21 Trillion for Americans (ad)

Your Watchlist

Analysts’ Upgrades

These 5 Stocks Are Already Moving Under Trump’s Presidency (ad)

Analysts’ Downgrades

These 5 Stocks Are Thriving Under Trump’s Presidency (ad)

Analysts’ New Coverage

Calendars from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Share this:

Like this:

Related articles